Archive · 25 Sep 2025
Eli Lilly's Weight-Loss Pill Orforglipron Shows Promise in India
A new weight-loss pill called orforglipron, made by Eli Lilly, is showing good results.
In tests, many people lost a significant amount of weight.
This pill works by affecting how the body handles sugar and appetite, similar to some existing drugs.
It's expected to be more accessible because it's a pill, which could help a lot of people in India struggling with weight and diabetes.
However, doctors say it's important to use it safely with a prescription, not as a quick fix.
It needs to be used with healthy diet and exercise to keep weight off.
Eli Lilly is developing the weight-loss pill orforglipron.
Orforglipron is a GLP-1 agonist.
In trials, 20% of participants lost 20% or more of their body weight.
The drug is intended to address obesity and diabetes.
Medical professionals recommend lifestyle changes to maintain results.
- Who
- Eli Lilly
- What
- Developing and potentially launching Orforglipron, a weight-loss pill.
- When
- Findings published in August in the New England Journal of Medicine.
- Where
- India
- Why
- Addresses obesity and diabetes in India; addresses the high cost and storage problems of weight loss injections.
- Company
- Eli Lilly
- Drug Name
- Orforglipron
- Target
- Weight Loss & Diabetes
- Method
- GLP-1 Agonist (Pill)
- Trial Result
- 20% weight loss in 20% of patients
- Potential issue
- Side effects and requirement of doctor's prescription